Medicines Blog Posts

• Lithium is best at decreasing the risk of depression-related hospitalisation in bipolar disorder, according to new cohort study

  03 Apr 2025

  • Duncan Swiffen

  
• Quetiapine may pip lithium to the post for augmentation in ‘treatment resistant depression’: results from the LQD study

  19 Mar 2025

  • Kirsten Lawson
  • and Douglas Badenoch

  
• Will this ADHD medication help my patient? Bridging the gap between efficacy and effectiveness

  07 Jan 2025

  • Shuichi Suetani

  
• KarXT: an innovative and promising treatment for schizophrenia

  20 Nov 2024

  • Nicola Rizzo Pesci
  • and Andrea Cipriani

  
• Psychotropic medication during pregnancy: new umbrella review finds no convincing evidence of adverse health outcomes for the baby

  18 Nov 2024

  • Flo Martin

  
• New and emerging treatments for major depressive disorder

  21 Aug 2024

  • Kirsten Lawson

  
• Using the highs to combat the lows: ketamine-assisted therapy for anxiety and depression

  20 Oct 2023

  • Gabrielle Williams

  
• Third molar surgery and antibiotic use

  06 Sep 2023

  • Derek Richards

  
• Ketamine and suicidal ideation: French trial finds modest short-term effects

  01 Feb 2023

  • Anya Borissova

  
• Ketamine “shows promise” as an anti-suicidal ideation agent, but will this promise ever be realised?

  23 Feb 2022

  • Rosalind McAlpine
  • and Karel Kieslich